"10.1371_journal.ppat.1000984","plos pathogens","2010-07-08T00:00:00Z","Don B Gammon; Branawan Gowrishankar; Sophie Duraffour; Graciela Andrei; Chris Upton; David H Evans","Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada; Laboratory of Virology and Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium; Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada","Conceived and designed the experiments: DBG DHE. Performed the experiments: DBG BG SD GA CU. Analyzed the data: DBG BG SD GA CU DHE. Wrote the paper: DBG DHE.","Financial competing interest: A provisional U.S. patent application (No. 61/224,694) has been submitted by DBG and DHE entitled “Oncolytic Viruses and Methods for Treating Neoplastic Disorders” for the use of poxviruses deficient in ribonucleotide reductase genes as oncolytic agents.","2010","07","Don B Gammon","DBG",6,TRUE,2,5,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
